Researchers test treatment to inoculate against the autoimmune disease
A vaccine 'cure' for rheumatoid arthritis could be available in five years. The treatment involves a sample of white blood cells being treated with steroids and vitamins to transform them into a more 'tolerant' state before being injected back into the patient. A team at Newcastle University is about to begin small-scale safety trials of the therapy that will come in the form of a single injection. The research, funded by the Arthritis Research Campaign, involves modified dendritic cells that are hoped to return the body to its pre-disease state meaning the immune system will no longer ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes